BAC / Charsire Biotech - LARVOL DELTA

CSTC1 for Diabetic Foot Ulcers Phase II Study (clinicaltrials.gov) - P2; N=124; Completed; Sponsor: Charsire Biotechnology Corp.; Recruiting ➔ Completed; Trial completion date: Jun 2020 ➔ Jan 2020

Clinical • Trial completion • Trial completion date • Diabetes • Metabolic Disorders

CSTC1 for Diabetic Foot Ulcers Phase II Study (clinicaltrials.gov) - P2; N=100; Recruiting; Sponsor: Charsire Biotechnology Corp.; Trial completion date: Sep 2019 ➔ Jun 2020; Trial primary completion date: Sep 2019 ➔ Mar 2020

Clinical • Trial completion date • Trial primary completion date